AAPL349.52+5.69 (+1.65%) ▲|ABBV291.18+5.19 (+1.81%) ▲|ABT103.62+0.98 (+0.95%) ▲|ACN243.66+0.26 (+0.10%) ▲|ADBE247.70-2.06 (-0.82%) ▼|AMAT416.25+0.25 (+0.06%) ▲|AMD568.12-10.32 (-1.78%) ▼|AMGN465.24+13.41 (+2.97%) ▲|AMT185.10+1.35 (+0.73%) ▲|AMZN246.26-8.34 (-3.28%) ▼|AVGO342.50-9.32 (-2.65%) ▼|AXP325.34+7.40 (+2.33%) ▲|BA170.33+3.19 (+1.91%) ▲|BAC51.76+0.91 (+1.78%) ▲|BKNG151.34+3.40 (+2.30%) ▲|BLK1,175.81+17.93 (+1.55%) ▲|BMY60.30-0.27 (-0.45%) ▼|BNY149.42+0.83 (+0.56%) ▲|BRK-B544.87+4.53 (+0.84%) ▲|C126.14+2.03 (+1.64%) ▲|CAT660.01-53.38 (-7.48%) ▼|CL91.89+0.20 (+0.21%) ▲|CMCSA21.82+0.25 (+1.16%) ▲|COF208.56+3.68 (+1.80%) ▲|COP149.82+0.76 (+0.51%) ▲|COST986.49+3.76 (+0.38%) ▲|CRM232.91-9.20 (-3.80%) ▼|CSCO109.78-0.51 (-0.46%) ▼|CVS91.12+1.17 (+1.30%) ▲|CVX231.09+1.89 (+0.82%) ▲|DE642.73+2.06 (+0.32%) ▲|DHR235.33+1.26 (+0.54%) ▲|DIS110.41+1.37 (+1.26%) ▲|DUK125.00+1.43 (+1.16%) ▲|EMR169.24+1.53 (+0.91%) ▲|FDX302.21-2.37 (-0.78%) ▼|GD366.11+11.76 (+3.32%) ▲|GE310.12+8.99 (+2.99%) ▲|GEV910.54+32.51 (+3.70%) ▲|GILD162.32+3.12 (+1.96%) ▲|GM83.90+1.42 (+1.72%) ▲|GOOG283.34-38.55 (-11.98%) ▼|GOOGL285.45-39.44 (-12.14%) ▼|GS934.98+9.81 (+1.06%) ▲|HD324.25+6.69 (+2.11%) ▲|HON217.91-1.35 (-0.62%) ▼|IBM253.97+0.75 (+0.30%) ▲|INTC93.11-2.42 (-2.53%) ▼|INTU330.88+2.69 (+0.82%) ▲|ISRG445.80+1.62 (+0.36%) ▲|JNJ274.67+3.63 (+1.34%) ▲|JPM345.18+5.88 (+1.73%) ▲|KO92.45+0.72 (+0.78%) ▲|LIN502.00-6.16 (-1.21%) ▼|LLY1,384.73+96.43 (+7.48%) ▲|LMT642.53+12.78 (+2.03%) ▲|LOW203.16+4.76 (+2.40%) ▲|LRCX258.03+4.21 (+1.66%) ▲|MA638.11+27.80 (+4.55%) ▲|MCD254.90+4.40 (+1.75%) ▲|MDLZ62.04+0.17 (+0.27%) ▲|MDT95.35+0.57 (+0.60%) ▲|META623.57+11.08 (+1.81%) ▲|MMM175.54+2.74 (+1.59%) ▲|MO75.79+2.80 (+3.83%) ▲|MRK146.79+5.86 (+4.15%) ▲|MS192.41+2.28 (+1.20%) ▲|MSFT524.28-6.73 (-1.27%) ▼|MU955.79-27.44 (-2.79%) ▼|NEE81.88+0.86 (+1.06%) ▲|NFLX62.09+0.10 (+0.15%) ▲|NKE38.22+1.07 (+2.88%) ▲|NOW113.63-36.50 (-24.31%) ▼|NVDA213.78-1.60 (-0.74%) ▼|ORCL140.26-4.29 (-2.96%) ▼|PEP133.00+0.37 (+0.28%) ▲|PFE29.69+0.24 (+0.80%) ▲|PG158.87+0.61 (+0.39%) ▲|PLTR195.59-1.22 (-0.62%) ▼|PM205.45+2.81 (+1.39%) ▲|QCOM181.31-1.66 (-0.91%) ▼|RTX195.84+1.24 (+0.64%) ▲|SBUX103.20+0.16 (+0.16%) ▲|SCHW88.76-0.54 (-0.60%) ▼|SO91.52-1.13 (-1.22%) ▼|SPG211.24-1.04 (-0.49%) ▼|T20.70-0.24 (-1.15%) ▼|TMO704.94+0.79 (+0.11%) ▲|TMUS149.97+1.89 (+1.27%) ▲|TSLA403.77-0.45 (-0.11%) ▼|TXN309.83+0.92 (+0.30%) ▲|UBER65.27-0.51 (-0.78%) ▼|UNH407.10-3.29 (-0.80%) ▼|UNP297.80-2.08 (-0.69%) ▼|UPS105.62-0.47 (-0.44%) ▼|USB59.60-0.14 (-0.23%) ▼|V400.60-1.26 (-0.31%) ▼|VZ43.18-0.75 (-1.71%) ▼|WFC83.67+1.01 (+1.22%) ▲|WMT118.77-0.55 (-0.46%) ▼|XOM182.02+2.11 (+1.17%) ▲|AAPL349.52+5.69 (+1.65%) ▲|ABBV291.18+5.19 (+1.81%) ▲|ABT103.62+0.98 (+0.95%) ▲|ACN243.66+0.26 (+0.10%) ▲|ADBE247.70-2.06 (-0.82%) ▼|AMAT416.25+0.25 (+0.06%) ▲|AMD568.12-10.32 (-1.78%) ▼|AMGN465.24+13.41 (+2.97%) ▲|AMT185.10+1.35 (+0.73%) ▲|AMZN246.26-8.34 (-3.28%) ▼|AVGO342.50-9.32 (-2.65%) ▼|AXP325.34+7.40 (+2.33%) ▲|BA170.33+3.19 (+1.91%) ▲|BAC51.76+0.91 (+1.78%) ▲|BKNG151.34+3.40 (+2.30%) ▲|BLK1,175.81+17.93 (+1.55%) ▲|BMY60.30-0.27 (-0.45%) ▼|BNY149.42+0.83 (+0.56%) ▲|BRK-B544.87+4.53 (+0.84%) ▲|C126.14+2.03 (+1.64%) ▲|CAT660.01-53.38 (-7.48%) ▼|CL91.89+0.20 (+0.21%) ▲|CMCSA21.82+0.25 (+1.16%) ▲|COF208.56+3.68 (+1.80%) ▲|COP149.82+0.76 (+0.51%) ▲|COST986.49+3.76 (+0.38%) ▲|CRM232.91-9.20 (-3.80%) ▼|CSCO109.78-0.51 (-0.46%) ▼|CVS91.12+1.17 (+1.30%) ▲|CVX231.09+1.89 (+0.82%) ▲|DE642.73+2.06 (+0.32%) ▲|DHR235.33+1.26 (+0.54%) ▲|DIS110.41+1.37 (+1.26%) ▲|DUK125.00+1.43 (+1.16%) ▲|EMR169.24+1.53 (+0.91%) ▲|FDX302.21-2.37 (-0.78%) ▼|GD366.11+11.76 (+3.32%) ▲|GE310.12+8.99 (+2.99%) ▲|GEV910.54+32.51 (+3.70%) ▲|GILD162.32+3.12 (+1.96%) ▲|GM83.90+1.42 (+1.72%) ▲|GOOG283.34-38.55 (-11.98%) ▼|GOOGL285.45-39.44 (-12.14%) ▼|GS934.98+9.81 (+1.06%) ▲|HD324.25+6.69 (+2.11%) ▲|HON217.91-1.35 (-0.62%) ▼|IBM253.97+0.75 (+0.30%) ▲|INTC93.11-2.42 (-2.53%) ▼|INTU330.88+2.69 (+0.82%) ▲|ISRG445.80+1.62 (+0.36%) ▲|JNJ274.67+3.63 (+1.34%) ▲|JPM345.18+5.88 (+1.73%) ▲|KO92.45+0.72 (+0.78%) ▲|LIN502.00-6.16 (-1.21%) ▼|LLY1,384.73+96.43 (+7.48%) ▲|LMT642.53+12.78 (+2.03%) ▲|LOW203.16+4.76 (+2.40%) ▲|LRCX258.03+4.21 (+1.66%) ▲|MA638.11+27.80 (+4.55%) ▲|MCD254.90+4.40 (+1.75%) ▲|MDLZ62.04+0.17 (+0.27%) ▲|MDT95.35+0.57 (+0.60%) ▲|META623.57+11.08 (+1.81%) ▲|MMM175.54+2.74 (+1.59%) ▲|MO75.79+2.80 (+3.83%) ▲|MRK146.79+5.86 (+4.15%) ▲|MS192.41+2.28 (+1.20%) ▲|MSFT524.28-6.73 (-1.27%) ▼|MU955.79-27.44 (-2.79%) ▼|NEE81.88+0.86 (+1.06%) ▲|NFLX62.09+0.10 (+0.15%) ▲|NKE38.22+1.07 (+2.88%) ▲|NOW113.63-36.50 (-24.31%) ▼|NVDA213.78-1.60 (-0.74%) ▼|ORCL140.26-4.29 (-2.96%) ▼|PEP133.00+0.37 (+0.28%) ▲|PFE29.69+0.24 (+0.80%) ▲|PG158.87+0.61 (+0.39%) ▲|PLTR195.59-1.22 (-0.62%) ▼|PM205.45+2.81 (+1.39%) ▲|QCOM181.31-1.66 (-0.91%) ▼|RTX195.84+1.24 (+0.64%) ▲|SBUX103.20+0.16 (+0.16%) ▲|SCHW88.76-0.54 (-0.60%) ▼|SO91.52-1.13 (-1.22%) ▼|SPG211.24-1.04 (-0.49%) ▼|T20.70-0.24 (-1.15%) ▼|TMO704.94+0.79 (+0.11%) ▲|TMUS149.97+1.89 (+1.27%) ▲|TSLA403.77-0.45 (-0.11%) ▼|TXN309.83+0.92 (+0.30%) ▲|UBER65.27-0.51 (-0.78%) ▼|UNH407.10-3.29 (-0.80%) ▼|UNP297.80-2.08 (-0.69%) ▼|UPS105.62-0.47 (-0.44%) ▼|USB59.60-0.14 (-0.23%) ▼|V400.60-1.26 (-0.31%) ▼|VZ43.18-0.75 (-1.71%) ▼|WFC83.67+1.01 (+1.22%) ▲|WMT118.77-0.55 (-0.46%) ▼|XOM182.02+2.11 (+1.17%) ▲|
12.9 C
New York
Thursday, October 29, 2026

Tag: oral

newsFORsourcecompanycontentinformationreleases1market

Basilea announces in-licensing of a novel clinical phase 3-ready oral antibiotic

Ad hoc announcement pursuant to Art. 53 LR

Basilea gibt Einlizenzierung eines neuartigen oralen Antibiotikums bekannt, das bereit für die klinische Phase-3-Entwicklung ist

Ad hoc-Mitteilung gemäss Art. 53 KR

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY® by the Taiwan Food and Drug Administration for the Treatment of Moderately to...

SHANGHAI, Aug. 14, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing...

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reschedules Second Quarter 2025 Financial Results Release to August 19, 2025

Conference Call 8:00am ET, Wednesday August 20, 2025 WILMINGTON, Del., Aug. 13, 2025 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a...

Applied Therapeutics Reports Second Quarter 2025 Financial Results

- CMT-SORD program advances; meeting scheduled with the FDA in Q3 2025 to discuss govorestat for the treatment of CMT-SORD

Stardust Power Announces Q2 2025 Financial Results

Stardust Power Q2 2025 earnings release

FIEE Announces Fiscal 2025 First Half Unaudited Financial Results

First Half Revenue of $45,118Prepaid subscription fees received from customers for our SaaS service were $1.5 Million. HONG KONG, Aug. 13, 2025 /PRNewswire/ -- FiEE,...

Infosys and Telstra Announce Joint Venture in Australia

Accelerating AI-powered Cloud & Digital transformation for Australian enterprises BENGALURU, India and MELBOURNE, Australia, Aug. 13, 2025 /PRNewswire/ -- Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY),...

High-tech Health for Students: Health-E Commerce® Highlights 10 Ways to Use Flexible Spending Accounts (FSA) and Health Savings Accounts (HSAs) for Digital Healthcare Products...

Tax-free FSA and HSA funds can be used to purchase health devices at FSA Store and HSA Store that treat conditions like acne, diabetes,...

Daewoong Therapeutics Microneedle Patch Achieves Best-in-Class Bioavailability, Proving the Strength of Its Drug-Delivery Platform

More than 80% relative bioavailability compared with injectable obesity therapy, well above the roughly 30% reported for existing microneedle patches and setting a new...

COLGATE DENTAL VEER ANTHEM LAUNCHED TO EMPOWER KIDS TO BE THEIR OWN HEROES OF ORAL HEALTH

Released close to Independence Day, the anthem is penned by lyricist Swanand Kirkire and composed by Micu Patel Link to the anthem - Colgate Dental...

Greywolf Therapeutics begins dosing of the first treatment to target the antigenic source of autoimmunity

Greywolf starts first trial of GRWD0715, aiming for a functional cure for autoimmunity by targeting its antigenic source.

Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, Demonstrated Greater Efficacy with Tirzepatide than Semaglutide in a Preclinical Model

-         The combination of ASC47 low dose with tirzepatide in diet-induced obese (DIO) mice resulted in an 87% greater reduction in...

Artemis Gold Reports Q2 2025 Results Consistent with Guidance: Q2 Production of 50,623 ounces gold and Post-commercial AISC US$805 per ounce, and Announces $700M...

TSXV: ARTG (all amounts in Canadian dollars unless otherwise stated) VANCOUVER, BC, Aug. 12, 2025 /CNW/ - Artemis Gold Inc. (TSXV: ARTG) ("Artemis Gold" or the...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsOral

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers